His Drug course of study focuses on Pharmacology and Prodrug. His work on Immunology as part of general Multiple myeloma study is frequently linked to Cancer research, therefore connecting diverse disciplines of science. His Multiple myeloma research extends to Immunology, which is thematically connected. In his works, Christoph Rader conducts interdisciplinary research on Cancer research and Leukemia. While working in this field, Christoph Rader studies both Leukemia and Chronic lymphocytic leukemia. His research on Cell biology often connects related areas such as Cell adhesion molecule and Extracellular. In most of his Extracellular studies, his work intersects topics such as Cell biology. Christoph Rader is involved in relevant fields of research such as Catalysis and Polymer in the domain of Organic chemistry. He performs multidisciplinary study in the fields of Catalysis and Organic chemistry via his papers.
Christoph Rader frequently studies issues relating to Chronic lymphocytic leukemia and Immunology. His Chronic lymphocytic leukemia study frequently draws connections to other fields, such as Immunology. He integrates Biochemistry with Cell biology in his study. Christoph Rader connects Cell biology with Biochemistry in his study. He connects Monoclonal antibody with Phage display in his research. He merges Phage display with Monoclonal antibody in his research. He connects Cancer research with Leukemia in his research. While working in this field, Christoph Rader studies both Leukemia and Cancer research. While working in this field, he studies both Molecular biology and Gene.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
SARS-CoV-2 spike-protein D614G mutation increases virion spike density and infectivity
Lizhou Zhang;Cody B. Jackson;Huihui Mou;Amrita Ojha.
Nature Communications (2020)
Humanization of murine antibody
Barbas Carlos F;Rader Christoph.
Receptor Affinity and Extracellular Domain Modifications Affect Tumor Recognition by ROR1-Specific Chimeric Antigen Receptor T Cells
Michael Hudecek;Maria Teresa Lupo-Stanghellini;Paula L. Kosasih;Daniel Sommermeyer.
Clinical Cancer Research (2013)
The Nonsignaling Extracellular Spacer Domain of Chimeric Antigen Receptors Is Decisive for In Vivo Antitumor Activity
Michael Hudecek;Michael Hudecek;Daniel Sommermeyer;Paula L. Kosasih;Anne Silva-Benedict;Anne Silva-Benedict.
Cancer immunology research (2015)
Phage display of combinatorial antibody libraries.
Christoph Rader;Carlos F Barbas.
Current Opinion in Biotechnology (1997)
A phage display approach for rapid antibody humanization: Designed combinatorial V gene libraries
Christoph Rader;David A. Cheresh;Carlos F. Barbas.
Proceedings of the National Academy of Sciences of the United States of America (1998)
The B-cell tumor-associated antigen ROR1 can be targeted with T cells modified to express a ROR1-specific chimeric antigen receptor.
Michael Hudecek;Michael Hudecek;Thomas M. Schmitt;Sivasubramanian Baskar;Maria Teresa Lupo-Stanghellini.
The Nogo-66 Receptor Homolog NgR2 Is a Sialic Acid-Dependent Receptor Selective for Myelin-Associated Glycoprotein
Karthik Venkatesh;Onanong Chivatakarn;Hakjoo Lee;Pushkar S. Joshi.
The Journal of Neuroscience (2005)
Methods for the generation of chicken monoclonal antibody fragments by phage display.
Jennifer Andris-Widhopf;Christoph Rader;Peter Steinberger;Roberta Fuller.
Journal of Immunological Methods (2000)
Unique cell surface expression of receptor tyrosine kinase ROR1 in human B-cell chronic lymphocytic leukemia.
Sivasubramanian Baskar;Ka Yin Kwong;Thomas Hofer;Jessica M Levy.
Clinical Cancer Research (2008)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: